Flynn James E Insider Trades

Insider Trading History

Track insider trading activity for Flynn James E. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Nuvalent
Nuvalent NUVL
10% owner, other, Director By Deputization
Holding Value $0 0 shares
Last Trade
Jul 15, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$429M 3,457,007 shares
$123.96
$123.96
Nuvalent
Nuvalent NUVL
10% owner, other, Director By Deputization
Holding Value $0 0 shares
Last Trade
Jul 15, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$638k 5,146 shares
$124.00
$123.96
Nuvalent
Nuvalent NUVL
10% owner, other, Director By Deputization
Holding Value $427k 3,444 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$425k 3,444 shares
$123.35
$123.96
Parabilis Medicines
Parabilis Medicines PBLS
10% owner, other, Possible Member Of 10% Group
Holding Value $30M 940,352 shares
Last Trade
Jun 11, 2026 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
No data
No data
$31.91
Parabilis Medicines
Parabilis Medicines PBLS
10% owner, other, Possible Member Of 10% Group
Holding Value $0 0 shares
Last Trade
Jun 11, 2026 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
No data
No data
$31.91
Parabilis Medicines
Parabilis Medicines PBLS
10% owner, other, *possible Member Of 10% Group
Holding Value $0 0 shares
Last Trade
Jun 09, 2026 Sale
No data
No data
$31.91
Larimar Therapeutics
Larimar Therapeutics LRMR
10% owner, other, * Director By Deputization
Holding Value $173k 55,150 shares
Last Trade
May 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$184k 55,150 shares
$3.33
$3.14
Larimar Therapeutics
Larimar Therapeutics LRMR
10% owner, other, * Director By Deputization
Holding Value $33.4M 10,622,957 shares
Last Trade
Feb 27, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$25M 5,000,000 shares
$5.00
$3.14
Nuvalent
Nuvalent NUVL
10% owner, other, Director By Deputization
Holding Value $1.03B 8,299,225 shares
Last Trade
Nov 24, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$40.7M 371,287 shares
$109.53
$123.96
Larimar Therapeutics
Larimar Therapeutics LRMR
10% owner, other, * Director By Deputization
Holding Value $30M 9,538,945 shares
Last Trade
Jul 31, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$30M 9,375,000 shares
$3.20
$3.14
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
10% owner
Holding Value $21.5M 4,887,254 shares
Last Trade
Jun 27, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.83M 370,074 shares
$18.46
$4.40
Nuvalent
Nuvalent NUVL
10% owner, other, Director By Deputization
Holding Value $514k 4,147 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$313k 4,147 shares
$75.53
$123.96
Larimar Therapeutics
Larimar Therapeutics LRMR
10% owner, other, * Director By Deputization
Holding Value $59.7k 19,000 shares
Last Trade
May 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35.7k 19,000 shares
$1.88
$3.14
BiomX
BiomX PHGE
other, *director By Deputization
Holding Value $2.98M 1,611,864 shares
Last Trade
Apr 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$880k 1,611,864 shares
$0.55
$1.85
BiomX
BiomX PHGE
other, *director By Deputization
Holding Value $32.6k 17,600 shares
Last Trade
Apr 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.5k 17,600 shares
$0.54
$1.85
BiomX
BiomX PHGE
other, *director By Deputization
Holding Value $2.33M 1,258,614 shares
Last Trade
Feb 27, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$856k 1,258,614 shares
$0.68
$1.85
BiomX
BiomX PHGE
other, *director By Deputization
Holding Value $750k 405,637 shares
Last Trade
Feb 27, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.1M 1,611,863 shares
$0.68
$1.85
BiomX
BiomX PHGE
other, *director By Deputization
Holding Value $2.31M 1,247,054 shares
Last Trade
Feb 27, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$240k 353,249 shares
$0.68
$1.85
Acutus Medical
Acutus Medical AFIB
other, Director By Deputization
Holding Value $0 0 shares
Last Trade
Jan 27, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$117k 2,130,621 shares
$0.06
$0.00
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
10% owner
Holding Value $24.2M 5,498,368 shares
Last Trade
Nov 11, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$708k 40,596 shares
$17.45
$4.40

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up